Inhibition of cAMP mediated relaxation in rat coronary vessels by block of CA++ activated K+ channels

Life Sciences

Volumn 58, Issue 24, 1996, Pages 2225-2232

  Price, J M ^a   Cabell, J F ^a   Hellermann, A ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

CAMP; Coronary vessels; K+ channel; Myogenic tone; Resistance vessel; Vasodilation

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 8 BROMO CYCLIC AMP; ACETYLCHOLINE; ADENOSINE; FORSKOLIN; IBERIOTOXIN; ISOPRENALINE; NITROPRUSSIDE SODIUM; POTASSIUM CHANNEL; POTASSIUM CHLORIDE; TETRYLAMMONIUM; THROMBOXANE A2 DERIVATIVE;

ANIMAL TISSUE; ARTERIAL PRESSURE; ARTERY DIAMETER; ARTICLE; BLOOD VESSEL TONE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY DILATATION; DRUG INHIBITION; NONHUMAN; RAT; RESISTANCE BLOOD VESSEL; SMOOTH MUSCLE RELAXATION;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; 8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ADENOSINE; ANIMALS; CALCIUM; CORONARY VESSELS; CYCLIC AMP; MUSCLE RELAXATION; NITROPRUSSIDE; POTASSIUM CHANNEL BLOCKERS; PROSTAGLANDIN ENDOPEROXIDES, SYNTHETIC; RATS; THROMBOXANE A2; VASCULAR RESISTANCE;

ANIMALIA;

EID: 0029885457     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/0024-3205(96)00217-2     Document Type: Article

References (29)

1. A.L. BLATZ and K.L. MAGLEBY, Trends Neurosci. 10 463-467 (1987).
2. R. Latorre, A. Oberhauser, P. Labarca and O. Alvarez, Annu. Rev. Physiol. 51 385-399 (1989).
3. A.H. GITTER, K.W. BEYENBACH, C.W. CHADWICK, P. GROSS, W. MINUTH and E. FROMTER, Pfluegers Arch. 408 282-290 (1987).
4. R.W. MEECH, Annu. Rev. Biophys. Bioeng. 7 1-18 (1978).
5. A. CARL, J.L. KENYON, D. UEMURA, N. FUSETANI and K.M. SANDERS, J. Physiol. 261 C387-C392 (1991).
6. P.H. REINHART, S. CHUNG, B.L. MARTIN, D.L. BRAUTIGAN and I.B. LEVITAN, J. Neurosci. 11 1627-1635 (1991).
7. G. BKAILY, Prog. Clin. Biol. Res. 327 507-515 (1990).
8. K. FUJINO, S. NAKAYA, T. WAKATSUKI, Y. MIYOSHI, Y. NAKAYA, H. MORI and I. INOUE, J. Pharmacol. Exp. Ther. 256 371-377 (1991).
9. B.E. ROBERTSON, R. SCHUBERT, J. HESCHELER and M.T. NELSON, Am. J. Physiol 265 C299-C303 (1993).
10. J.E. BRAYDEN and M.T. NELSON, Science Wash. DC 256 532-535 (1992).
11. F. CABELL, D.S. WEISS and J.M. PRICE, Am. J. Physiol. 267 H1455-H1460 (1994).
12. Z. ZHOU, J.M. PRICE, E.T. SUTTON, and C.H. BAKER, Life Sciences 54 9-16 (1994).
13. C.H. BAKER, E.T. SUTTON, J.M. PRICE, M. ORTIZ-TWEED and S. NESSELROTH, Am. J. Physiol. 267 H2171-H2178 (1994).
14. I. FLEMING, G. JULOU-SCHAEFFER, G.A. GRAY, J.R. PARATT, and J.C. STOCLET, Br. J. Pharm. 103 1047-1052 (1991).
15. W. HALPERN, G. OSOL and G.S. COY, Ann. Biomed. Eng. 12 463-479 (1984).
16. M.T. NELSON, J.B. PATLAK, J.F. WORLEY and N.B. STANDEN, Am. J. Physiol. 259 C3-C18 (1990).
17. J. SHAFIQ, S. SUZUKI, T. ITOH and H. KURIYAMA, Circ. Res. 71:70-81 (1992).
18. J. SADOSHIMA, N. AKAIKE, H. KANAIDE and M. NAKAMURA, Am. J. Physiol. 255 H754-H759 (1988).
19. F.S. SCORNIK, J. CODINA, L. BIRNBAUMER and L. TORO, Am. J. Physiol. 265 H1460-H1465 (1993).
20. H. KUME, A. TAKAI, H. TOKUNO and T. TOMITA, Nature 341 152-154 (1989).
21. S.J .GOLDMAN, E.S. DICKINSON and L.L. SLAKEY, J. Cyclic Nucleotide Protein Phosphorylation Res. 9 69-78 (1983).
22. S. KUSACHI, R.D. THOMPSON and R. A. OLSSON, J. Pharmacol. Exp. Ther. 227 316-321 (1983).
23. K. ORITO, K. SATOH, N. TAIRA, Eur. J. Pharmacol. 231 183-189 (1993).
24. F. YONEYAMA, H. YAMADE, K. SATOH and N. TAIRA, Eur J. Pharmacol 213 199-204 (1992).
25. M.T. NELSON and J.M. QUAYLE, Am. J. Physiol 268 C799-C822 (1995).
26. J.R. FOZARD and A.M. CARRUTHERS, Naunyn-Schmiedeberg's Arch. Pharmacol. 347 192-196 (1993).
27. S.R. MAKUJINA, H.A. OLANREWAJU and S.J. MUSTAFA, Am. J. Physiol. 267 H716-H724 (1994).
28. M. KAGEYAMA, T. YANAGISAWA and N. TAIRA, J. Pharmacol. Exp. Ther. 265 490-497 (1993).
29. J. TANIGUCHI, K. FURUKAWA and M. SHIGEKAWA, Pfluegers Arch. 423 167-172 (1993).